Published in Pharma Law Weekly, January 9th, 2007
This trend article about National Research Council, Spain, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Scientists have synthesized 16-mercaptohexadecylphosphocholine, a miltefosine analog with leishmanicidal activity.
"The alkylphosphocholine miltefosine (n-hexadecylphosphocholine, NIT) has been introduced recently as a very effective drug for the oral treatment of human leishmaniasis. However, the parasiticidal mechanism of MT at a molecular level is far from being understood," investigators writing in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2007-01-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.